5 Tech Stocks to Buy Immediately
Eric Fry, one of America's top Investment Strategists, provides his latest report 5 Top Stocks for 2022.

You can't afford to miss out on the once in a decade chance to buy after the recent dip in the markets.
Download this hot-off-the-presses research report now. It’s yours FREE.
Anthony Prentice, insider at Sema4
Anthony Prentice Insider Alerts

Get notified the next time Anthony Prentice buys or sells Sema4 stock. Enter your email address below to get our daily insider buying and selling report.

Anthony Prentice Insider Information

Insider of Sema4
Tony Prentice is an innovative product developer, strategist, and leader with extensive experience building and running product, marketing, and partnership organizations. His career spans multiple industries including big data, healthcare, mobile applications, customer experience, financial services, and consumer products.

As Sema4’s Chief Product Officer, Tony is responsible for the strategy and execution of all product-related activities including our patient apps, provider apps, information products for health systems and pharma, clinical software, and new product development of our genomic solutions in Oncology and Women’s Health.

Prior to joining Sema4, Tony served as the Vice President of Mobile Payments at American Express, where he built the organization for new commerce products, applications, and mobile wallets. The team delivered enterprise strategy and products including Apple Pay, Android Pay, and the Amex app.

Previously, Tony held other senior product management roles at American Express for Gold Card, Starwood, Hilton and Blue cards. Before American Express, Tony had various product, general manager, and engineering roles at Starbucks, McKinsey & Company, and General Electric.

How do I contact Anthony Prentice?

The corporate mailing address for Mr. Prentice and other Sema4 executives is 667 Madison Avenue, New York NY, 10065. Sema4 can also be reached via phone at 800-298-6470 and via email at [email protected]

Has Anthony Prentice been buying or selling shares of Sema4?

Anthony Prentice has not been actively trading shares of Sema4 during the last ninety days. Most recently, Anthony Prentice sold 1,620 shares of the business's stock in a transaction on Monday, October 25th. The shares were sold at an average price of $8.09, for a transaction totalling $13,105.80.

Who are Sema4's active insiders?

Sema4's insider roster includes Shawn Assad (CAO), Daniel Clark (General Counsel), James Coffin (COO), Anthony Prentice (Insider), Isaac Ro (CFO), and Eric Schadt (CEO).

Are insiders buying or selling shares of Sema4?

During the last twelve months, insiders at the sold shares 8 times. They sold a total of 117,553 shares worth more than $895,783.79. The most recent insider tranaction occured on November, 29th when CFO Isaac Ro sold 12,115 shares worth more than $80,322.45.

Information on this page was last updated on 11/29/2021.

Anthony Prentice Insider Trading History at Sema4

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
10/25/2021Sell1,620$8.09$13,105.80View SEC Filing Icon  
See Full Table

Anthony Prentice Buying and Selling Activity at Sema4

This chart shows Anthony Prentice's buying and selling at Sema4 by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Sema4 Company Overview

Sema4 logo
Sema4 Holdings Corp is a patient-centered health intelligence company. It is transforming healthcare by applying AI and machine learning to multidimensional, longitudinal clinical and genomic data to build dynamic models of human health and defining optimal, individualized health trajectories. Sema4 Holdings Corp, formerly known as CM Life Sciences, is based in STAMFORD, Conn.
Read More

Today's Range

Now: $3.08
Low: $3.07
High: $3.56

50 Day Range

MA: $5.26
Low: $3.08
High: $8.02

2 Week Range

Now: $3.08
Low: $3.07
High: $27.18

Volume

6,111,427 shs

Average Volume

2,377,567 shs

Market Capitalization

$743.08 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A
Little-Known Stock Mints Money From Apple's iPhone
The one company 350x smaller than Apple that could capitalize on the potential collapse of the iPhone.
Learn More.